Stock Based Compensation (Tables)
|
9 Months Ended |
Sep. 30, 2024 |
|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Summary of Stock Option Activity |
A summary of the status of the Company’s stock option activity and the changes during the nine months ended September 30, 2024, are as follows (in millions, except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
|
Weighted
Average
Exercise Price
Per Share |
|
|
Average
Remaining
Contractual
Term |
|
|
Aggregate
Intrinsic
Value |
|
Exercisable at December 31, 2023 |
|
|
1,859,740 |
|
|
|
8.78 |
|
|
|
6.4 |
|
|
|
50.7 |
|
Balance at December 31, 2023 |
|
|
2,881,208 |
|
|
|
12.02 |
|
|
|
7.0 |
|
|
|
69.6 |
|
Granted |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Exercised |
|
|
(527,533 |
) |
|
|
6.77 |
|
|
|
— |
|
|
|
— |
|
Forfeited |
|
|
(201,418 |
) |
|
|
23.02 |
|
|
|
— |
|
|
|
— |
|
Expired |
|
|
(48,225 |
) |
|
|
28.11 |
|
|
|
— |
|
|
|
— |
|
Balance at September 30, 2024 |
|
|
2,104,032 |
|
|
|
11.92 |
|
|
|
6.1 |
|
|
|
17.9 |
|
Exercisable at September 30, 2024 |
|
|
1,749,212 |
|
|
|
10.48 |
|
|
|
5.8 |
|
|
|
16.9 |
|
|
| Summary of Restricted Stock Unit Activity |
A summary of the status of the Company’s restricted stock unit activity and the changes during the nine months ended September 30, 2024 are as follows (in millions, except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
|
Weighted
Average
Grant Date fair value (per share) |
|
|
Aggregate
Intrinsic
Value |
|
Unvested RSUs as of December 31, 2023 |
|
|
1,769,874 |
|
|
|
22.50 |
|
|
|
63.6 |
|
Granted |
|
|
1,910,579 |
|
|
|
18.20 |
|
|
|
— |
|
Vested |
|
|
(631,023 |
) |
|
|
21.69 |
|
|
|
— |
|
Forfeited and cancelled |
|
|
(554,658 |
) |
|
|
22.15 |
|
|
|
— |
|
Unvested RSUs as of September 30, 2024 |
|
|
2,494,772 |
|
|
|
19.49 |
|
|
|
45.8 |
|
|
| Schedule of Total Stock-based Compensation Costs |
Total stock-based compensation cost for the three and nine months ended September 30, 2024 and 2023 were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
$ |
1,905 |
|
|
$ |
1,216 |
|
|
$ |
5,825 |
|
|
$ |
3,453 |
|
Operations and support |
|
|
2,235 |
|
|
|
1,955 |
|
|
|
6,568 |
|
|
|
5,690 |
|
Product development |
|
|
1,520 |
|
|
|
1,424 |
|
|
|
4,770 |
|
|
|
3,890 |
|
General and administrative |
|
|
1,294 |
|
|
|
1,135 |
|
|
|
3,952 |
|
|
|
3,189 |
|
Total stock compensation expense |
|
$ |
6,954 |
|
|
$ |
5,730 |
|
|
$ |
21,115 |
|
|
$ |
16,222 |
|
|
| Performance Restricted Stock Units |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Summary of Restricted Stock Unit Activity |
A summary of the status of the Company's performance restricted stock unit activity and the changes during the nine months ended September 30, 2024 are as follows (in millions, except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
|
Weighted
Average
Grant Date fair value (per share) |
|
|
Aggregate
Intrinsic
Value |
|
Unvested PRSUs as of December 31, 2023 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Granted |
|
|
336,118 |
|
|
|
17.35 |
|
|
|
— |
|
Vested |
|
|
- |
|
|
|
- |
|
|
|
— |
|
Forfeited and cancelled |
|
|
(63,603 |
) |
|
|
17.48 |
|
|
|
— |
|
Unvested PRSUs as of September 30, 2024 |
|
|
272,515 |
|
|
|
17.32 |
|
|
|
5.0 |
|
|